Targeting c-Met oncogene and the compensatory EGFR/ErbB3 pathways to eliminate c-Met activated hepatocellular carcinoma.

被引：0
|
作者：
Ding, Wei [1 ]
Hien Dang [1 ]
Steinway, Steven [1 ]
You, Hanning [1 ]
机构：
[1] Penn State Univ, Coll Med, Hershey, PA USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3393
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3393
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
    Steinway, Steven N.
    Dang, Hien
    You, Hanning
    Rountree, C. Bart
    Ding, Wei
    PLOS ONE, 2015, 10 (05):
  • [2] Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
    Goyal, Lipika
    Muzumdar, Mandar D.
    Zhu, Andrew X.
    CLINICAL CANCER RESEARCH, 2013, 19 (09) : 2310 - 2318
  • [3] Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma
    Gao, Jianjun
    Inagaki, Yoshinori
    Song, Peipei
    Qu, Xianjun
    Kokudo, Norihiro
    Tang, Wei
    PHARMACOLOGICAL RESEARCH, 2012, 65 (01) : 23 - 30
  • [4] A novel peptide targeting c-Met for hepatocellular carcinoma diagnosis
    Tang, Yongjia
    Xu, Haoran
    Dai, Yaxue
    Wang, Fang
    Huang, Wenjing
    Liu, Peifei
    Gu, Yueqing
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (22) : 4577 - 4586
  • [5] Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met
    Zaky, Mohamed Y.
    Liu, Xiuxiu
    Wang, Taishu
    Wang, Shanshan
    Liu, Fang
    Wang, Duchuang
    Wu, Yueguang
    Zhang, Yang
    Guo, Dong
    Sun, Qianhui
    Li, Qiong
    Zhang, Jinrui
    Zhang, Yingqiu
    Dong, Weijie
    Liu, Zhenhua
    Liu, Shuyan
    Liu, Han
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2020, 680
  • [6] C-MET OVEREXPRESSION IN HEPATOCELLULAR-CARCINOMA
    SUZUKI, K
    HAYASHI, N
    YAMADA, Y
    ITO, T
    MIYAMOTO, Y
    FUSAMOTO, H
    KAMADA, T
    HEPATOLOGY, 1993, 18 (04) : A155 - A155
  • [7] EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma
    Dong, Qiongzhu
    Du, Yi
    Li, Hui
    Liu, Chunxiao
    Wei, Yongkun
    Chen, Mei-Kuang
    Zhao, Xixi
    Chu, Yu-Yi
    Qiu, Yufan
    Qin, Lunxiu
    Yamaguchi, Hirohito
    Hung, Mien-Chie
    CANCER RESEARCH, 2019, 79 (04) : 819 - 829
  • [8] EGFR and c-MET cooperate to enhance PARP inhibitor resistance in hepatocellular carcinoma
    Dong, Qiongzhu
    Du, Yi
    Zhao, Xixi
    Li, Hui
    Liu, Chunxiao
    Wei, Yongkun
    Hung, Mien-chie
    CANCER RESEARCH, 2019, 79 (13)
  • [9] The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
    Wang, Haiyu
    Rao, Benchen
    Lou, Jiamin
    Li, Jianhao
    Liu, Zhenguo
    Li, Ang
    Cui, Guangying
    Ren, Zhigang
    Yu, Zujiang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [10] Caveolin and c-met interaction in hepatocellular carcinoma cells
    Cokakli, M.
    Erdal, E.
    Sagol, O.
    Karademir, S.
    Atabey, N.
    FEBS JOURNAL, 2006, 273 : 104 - 104
12345